William Grosh, MD
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Low-dose Interleukin-2 and Pembrolizumab in Melanoma and Renal Cell Cancer (NCT03111901) | William Grosh, MD | 2018-10-29 |
Track William Grosh, MD automatically
Every clearance here is in the API, with alerts when new ones post.